LEC-specific deletion of the TGF-β receptor type II (TGF-β RII) gene results in lymphatic dilation and impaired lymphatic drainage in a mouse model of Lewis lung carcinoma [132], indicating that suppression of TGF-β signaling in LECs might be effective in inhibiting cancer metastasis. This evidence concerns the gene TGFB1 and cancer.